Completed PHASE2 INTERVENTIONAL 2-arm NCT01040286

The Efficacy and Safety of Flurbiprofen Chip Versus Chlorhexidine Chip (Periochip®) in Therapy of Adult Chronic Periodontitis

Sponsor: Dexcel Pharma Technologies Ltd.

Interventions Chlorhexidine Flurbiprofen

Updated 5 times since 2017 Last updated: Jul 5, 2010 Started: Aug 31, 2009 Completion: Jun 30, 2010

This information is for research purposes only and is not medical advice. Consult a healthcare provider before making any medical decision.

This PHASE2 trial investigates Periodontitis and is currently completed. Dexcel Pharma Technologies Ltd. leads this study, which shows 5 recorded versions since 2009 — indicating limited longitudinal coverage. The change history captured here reflects the iterative nature of clinical trial conduct.

Status Flow

Change History

5 versions recorded

Sep 2024 — Present [monthly]

Completed PHASE2
Jul 2024 — Sep 2024 [monthly]

Completed PHASE2
Jan 2021 — Jul 2024 [monthly]

Completed PHASE2
Jun 2018 — Jan 2021 [monthly]

Completed PHASE2
Jan 2017 — Jun 2018 [monthly]

Completed PHASE2

First recorded

Aug 2009

Trial started

Per CT.gov start date — pre-dates our first snapshot

Eligibility Summary

No eligibility information available.

Contact Information

Sponsor contact:

Dexcel Pharma Technologies Ltd.

Data source: Dexcel Pharma Technologies Ltd.

For direct contact, visit the study record on ClinicalTrials.gov .

Study Locations

• Haifa, Israel